| Neil Baman, MD | |
|
200 Scenery Dr, State College, PA 16801-7974 | |
| (814) 231-4560 | |
| (814) 231-6246 |
| Full Name | Neil Baman |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology |
| Location | 200 Scenery Dr, State College, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285847053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MD437876 (Pennsylvania) | Primary |
| 207R00000X | Internal Medicine | MT188546 (Pennsylvania) | Secondary |
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
In recent years, a growing and potentially life-threatening trend known as Robo tripping, the abuse of over-the-counter cough and cold medications, has emerged among America's youth. As the Society representing the front-line physicians responsible for treating patients in the Intensive Care Unit (ICU) who have overdosed on over-the-counter medications, the American Society of Anesthesiologists (ASA) has developed information to help parents recognize the signs of Robo tripping and to prevent overdose and longer-term health complications.
In a new study published in Renewable & Sustainable Energy Reviews, a team from Michigan Technological University calculated the cost of combusting coal in terms of human lives along with the potential benefits of switching to solar.
Scientists used a gene editing method called CRISPR/Cas9 to generate mice that faithfully mimic a fatal respiratory disorder in newborn infants that turns their lips and skin blue. The new laboratory model allowed researchers to pinpoint the ailment's cause and develop a potential and desperately needed nanoparticle-based treatment.
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Levonorgestrel Tablets, 0.75 mg for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.
Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sensor, developed through its partnership with Precision Sensors Instrumentation (PSI), a leading developer of security sensors.
› Verified 6 days ago
| Entity Name | Allergy Asthma & Arthritis Associates P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952364739 PECOS PAC ID: 5395731566 Enrollment ID: O20040422001180 |
News Archive
In recent years, a growing and potentially life-threatening trend known as Robo tripping, the abuse of over-the-counter cough and cold medications, has emerged among America's youth. As the Society representing the front-line physicians responsible for treating patients in the Intensive Care Unit (ICU) who have overdosed on over-the-counter medications, the American Society of Anesthesiologists (ASA) has developed information to help parents recognize the signs of Robo tripping and to prevent overdose and longer-term health complications.
In a new study published in Renewable & Sustainable Energy Reviews, a team from Michigan Technological University calculated the cost of combusting coal in terms of human lives along with the potential benefits of switching to solar.
Scientists used a gene editing method called CRISPR/Cas9 to generate mice that faithfully mimic a fatal respiratory disorder in newborn infants that turns their lips and skin blue. The new laboratory model allowed researchers to pinpoint the ailment's cause and develop a potential and desperately needed nanoparticle-based treatment.
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Levonorgestrel Tablets, 0.75 mg for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.
Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sensor, developed through its partnership with Precision Sensors Instrumentation (PSI), a leading developer of security sensors.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neil Baman, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Neil Baman, MD 200 Scenery Dr, State College, PA 16801-7974 Ph: (814) 231-4560 |
News Archive
In recent years, a growing and potentially life-threatening trend known as Robo tripping, the abuse of over-the-counter cough and cold medications, has emerged among America's youth. As the Society representing the front-line physicians responsible for treating patients in the Intensive Care Unit (ICU) who have overdosed on over-the-counter medications, the American Society of Anesthesiologists (ASA) has developed information to help parents recognize the signs of Robo tripping and to prevent overdose and longer-term health complications.
In a new study published in Renewable & Sustainable Energy Reviews, a team from Michigan Technological University calculated the cost of combusting coal in terms of human lives along with the potential benefits of switching to solar.
Scientists used a gene editing method called CRISPR/Cas9 to generate mice that faithfully mimic a fatal respiratory disorder in newborn infants that turns their lips and skin blue. The new laboratory model allowed researchers to pinpoint the ailment's cause and develop a potential and desperately needed nanoparticle-based treatment.
Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Levonorgestrel Tablets, 0.75 mg for over-the-counter use in women ages 17 and above, as well as for prescription use in women under the age of 17.
Universal Detection Technology, a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today test results for its passive zone security sensor, developed through its partnership with Precision Sensors Instrumentation (PSI), a leading developer of security sensors.
› Verified 6 days ago
Dr. Faoud Ishmael, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave Ste 201, State College, PA 16803 Phone: 844-278-4600 Fax: 814-235-1133 | |
Sebastian Sylvestre, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1850 E Park Ave Ste 201, State College, PA 16803 Phone: 814-234-8800 Fax: 814-235-1133 | |
Dr. Robert A. Mentyka, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 200 Scenery Dr, State College, PA 16801 Phone: 814-231-4560 Fax: 814-235-5512 |